Trial
|
Studied treatment |
Control |
Patients |
Size |
Study type
|
Results |
NCT |
Percutaneous coronary intervention - antithrombotics in PCI with stent placement - antiplatelets drug in all type of patients |
Kunishima, 1997 | cilostazol | aspirin | | 70 (30/40) | | | |
Sekiya, 1998 | cilostazol + aspirin | aspirin | | 126 (63/63) | | | |
Kozuma, 2001 | cilostazol + aspirin | ticlopidine + aspirin | | 125 (62/63) | | | |
Ochiai, 1999 | cilostazol + aspirin | ticlopidine + aspirin | | 50 (25/25) | | | |
Park, 1999 | cilostazol + aspirin | ticlopidine + aspirin | | 490 (247/243) | | | |
Yoon, 1999 | cilostazol + aspirin | ticlopidine + aspirin | | 296 (147/149) | | | |
Kamishirado, 2002 | cilostazol + aspirin | ticlopidine + aspirin | | 130 (65/65) | | | |
|
Elam, 1998 | cilostazol | placebo | | NA | | | |
Otsuka 21-95-201 | cilostazol | placebo | | NA | | | |
Dawson, 1998 | cilostazol | placebo | | 81 (54/27) | | | |
Beebe, 1999 | cilostazol | placebo | | 516 (346/170) | | | |
Dawson (cilostazol), 2000 | cilostazol | placebo | | 466 (227/239) | | | |
Money, 1998 | cilostazol | placebo | | 239 (119/120) | | | |
Strandness, 2002 | cilostazol | placebo | | 394 (265/129) | | | |
Stent - antithrombotics in all type of patients |
Kunishima, 1997 | cilostazol | aspirin | | 70 (30/40) | | | |
Sekiya, 1998 | cilostazol + aspirin | aspirin | | 126 (63/63) | | | |
Kozuma, 2001 | cilostazol + aspirin | ticlopidine + aspirin | | 125 (62/63) | | | |
Ochiai, 1999 | cilostazol + aspirin | ticlopidine + aspirin | | 50 (25/25) | | | |
Park, 1999 | cilostazol + aspirin | ticlopidine + aspirin | | 490 (247/243) | | | |
Yoon, 1999 | cilostazol + aspirin | ticlopidine + aspirin | | 296 (147/149) | | | |
Kamishirado, 2002 | cilostazol + aspirin | ticlopidine + aspirin | | 130 (65/65) | | | |